Literature DB >> 680947

A new sensitive method for detecting human endogenous (leukocyte) pyrogen.

P Bodel, H Miller.   

Abstract

Endogenous, or leukocyte pyrogen (EP), the mediator of fever, is currently detected by injection of pyrogen-containing supernatants into rabbits. This assay has been of little value in the study of human fever because it required injection of relatively large amounts of pyrogen. We now report that injection of medium containing human EP produces fever in mice. Supernatant from 1 c 10(5) granulocytes, stimulated by phagocytosis of staphylococci and incubated overnight, or 1 x 10(4) monocytes similarly treated, produce clear pyrogenic responses. This method for detecting EP is about 100-fold more sensitive than the rabbit assay, and it appears to be specific for EP. Preliminary studies of EP released by small samples of needle liver biopsies from febrile and afebrile patients suggests that this sensitive assay may be useful for investigations into the mechanisms of clinical fever.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 680947     DOI: 10.1007/BF00917325

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  17 in total

1.  Temperature responses of mice to Escherichia coli endotoxin.

Authors:  D Prashker; A C Wardlaw
Journal:  Br J Exp Pathol       Date:  1971-02

2.  Purification of an endogenous pyrogen, with an appendix on assay methods.

Authors:  P A Murphy; P J Chesney; W B Wood
Journal:  Ciba Found Symp       Date:  1971

3.  Pyrogen from mouse macrophages causes fever in mice.

Authors:  P Bodel; H Miller
Journal:  Proc Soc Exp Biol Med       Date:  1976-01

4.  The dissociation by colchicine of phagocytosis from increased oxygen consumption in human leukocytes.

Authors:  S E Malawista; P T Bodel
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

5.  The production of antibody against human leukocytic pyrogen.

Authors:  C A Dinarello; L Renfer; S M Wolff
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

6.  Spontaneous pyrogen production by mouse histiocytic and myelomonocytic tumor cell lines in vitro.

Authors:  P Bodel
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

7.  Studies on the mechanism of endogenous pyrogen production. I. Investigation of new protein synthesis in stimulated human blood leucocytes.

Authors:  P Bodel
Journal:  Yale J Biol Med       Date:  1970-12

8.  Studies on the pathogenesis of fever. XI. Quantitative features of the febrile response to leucocytic pyrogen.

Authors:  D L BORNSTEIN; C BREDENBERG; W B WOOD
Journal:  J Exp Med       Date:  1963-03-01       Impact factor: 14.307

Review 9.  Pyrogen release in vitro by lymphoid tissues from patients with Hodgkin's disease.

Authors:  P Bodel
Journal:  Yale J Biol Med       Date:  1974

10.  Studies on the mechanism of endogenous pyrogen production. III. Human blood monocytes.

Authors:  P Bodel
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Molecular mechanisms in endotoxin fever.

Authors:  C A Dinarello
Journal:  Agents Actions       Date:  1983-08

2.  A pyrogen derived from human white cells which is active in mice.

Authors:  A H Gordon; I D Parker
Journal:  Br J Exp Pathol       Date:  1980-10

3.  Endogenous pyrogen production by Hodgkin's disease and human histiocytic lymphoma cell lines in vitro.

Authors:  P Bodel; P Ralph; K Wenc; J C Long
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

4.  Multiple biological activities of human recombinant interleukin 1.

Authors:  C A Dinarello; J G Cannon; J W Mier; H A Bernheim; G LoPreste; D L Lynn; R N Love; A C Webb; P E Auron; R C Reuben
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

5.  Further comparisons of endogenous pyrogens and leukocytic endogenous mediators.

Authors:  R F Kampschmidt; H F Upchurch; M L Worthington
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.